Down but not out: drugs that enhance delta oscillations but preserve consciousness
Joel Frohlich, Pedro A. M. Mediano, Francesco Bavato, Alireza Gharabaghi
January 30, 2023 preprint DOI: 10.31234/osf.io/tj2sw (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review |
|---|---|
| Citations | 1 |
| Key findings | The authors argue that drug challenge studies with antiepileptics, GABA-B-ergics, anticholinergics, and psychedelic tryptamines show a dissociation between neurophysiological 'down' states (diffuse high-amplitude delta EEG resembling cortical down states) and psychological 'out' states (unconsciousness), and propose that some of these substances may be valuable tools for investigating the neural patterns sufficient for consciousness or its absence. |
Abstract
Delta (1 – 4 Hz) EEG/MEG activity is generally indicative of loss of consciousness and cortical down states, particularly when it is diffuse and high amplitude. Remarkably, however, drug challenge studies of several diverse classes of pharmacological agents—including antiepileptics, GABA-B-ergics, anticholinergics, and psychedelic tryptamines—demonstrate that participants appear to be neurophysiologically “down” (EEG activity resembling cortical down states) even when they are not psychologically “out” (unconscious). Of those substances that are safe to use in healthy volunteers, some may be highly valuable research tools for investigating which neural activity patterns are sufficient for consciousness or its absence.
Citations in the library
Cites 20
- A Theoretically Based Index of Consciousness Independent of Sensory Processing and Behavior Science Translational Medicine August 14, 2013
- Stratification of unresponsive patients by an independently validated index of brain complexity Annals of Neurology September 22, 2016
- Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin Scientific Reports April 19, 2017
- Neural correlates of the DMT experience assessed with multivariate EEG. Scientific Reports November 19, 2019
- Reviewing the ketamine model for schizophrenia Journal of Psychopharmacology November 20, 2013
and 15 more in the library